Allogene Therapeutics
ALLO
ALLO
170 hedge funds and large institutions have $398M invested in Allogene Therapeutics in 2023 Q4 according to their latest regulatory filings, with 39 funds opening new positions, 50 increasing their positions, 52 reducing their positions, and 22 closing their positions.
Holders
170
Holders Change
+16
Holders Change %
+10.39%
% of All Funds
2.49%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
39
Increased
50
Reduced
52
Closed
22
Calls
$96K
Puts
$451K
Net Calls
-$355K
Net Calls Change
-$81K
Top Buyers
| 1 |
1
Morgan Stanley
New York
|
$10.7M |
| 2 |
2
Goldman Sachs
New York
|
$10.7M |
| 3 |
3
Millennium Management
New York
|
$6.16M |
| 4 |
4
BlackRock
New York
|
$32.1M |
| 5 |
5
Two Sigma Investments
New York
|
$7.43M |
